These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766 AND Clinical Outcome
956 results:

  • 1. Similar Survival But Less Chronic GVHD in Antithymocyte Globulin-Based Myeloablative Haploidentical Transplant Compared With Matched Sibling Transplant for Adult T-cell Acute Lymphoblastic leukemia/Lymphoma.
    Gu Z; Li F; Li M; Zhang L; Xu S; Wang L; Wang L; Jing Y; Bo J; Gao C; Dou L; Liu D
    Cell Transplant; 2024; 33():9636897241270401. PubMed ID: 39219184
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13).
    Weichenhan D; Riedel A; Sollier E; Toprak UH; Hey J; Breuer K; Wierzbinska JA; Touzart A; Lutsik P; Bähr M; Östlund A; Nilsson T; Jacobsson S; Edler M; Waraky A; Behrens YL; Göhring G; Schlegelberger B; Steinek C; Harz H; Leonhardt H; Dolnik A; Reinhardt D; Bullinger L; Palmqvist L; Lipka DB; Plass C
    Blood Adv; 2024 Oct; 8(19):5100-5111. PubMed ID: 39121370
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling.
    Cadot S; Audebert C; Dion C; Ken S; Dupré L; Largeaud L; Laurent C; Ysebaert L; Crauste F; Quillet-Mary A
    PLoS Med; 2024 Jul; 21(7):e1004430. PubMed ID: 39037964
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT).
    Galieni P; Troiani E; Picardi P; Angelini M; Mestichelli F; Dalsass A; Maravalle D; Camaioni E; Bigazzi C; Caraffa P; Ruggieri M; Mazzotta S; Mattioli S; Angelini S
    Leuk Res; 2024 Aug; 143():107541. PubMed ID: 38905908
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
    Labrador J; Martínez-Cuadrón D; Boluda B; Serrano J; Gil C; Pérez-Simón JA; Bernal T; Bergua JM; Martínez-López J; Rodríguez-Medina C; Vidriales MB; García-Boyero R; Algarra L; Polo M; Sayas MJ; Tormo M; Alonso-Domínguez JM; Herrera P; Lavilla E; Ramos F; Amigo ML; Vives-Polo S; Rodríguez-Macías G; Mena-Durán A; Pérez-Encinas MM; Arce-Fernández O; Cuello R; Sánchez-García J; Gómez-Casares MT; Chillón MC; Calasanz MJ; Ayala R; Rodriguez-Veiga R; Barragán E; Montesinos P;
    Cancer; 2024 Oct; 130(20):3436-3451. PubMed ID: 38896056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China.
    Zhang Z; Fu C; Sun Y; Liu Y; Wang Q; Yan W; Wu C; Wang Q; Zeng Z; Wen L; Shen H; Yao L; Liu D; Chen S; Pan J
    Ann Hematol; 2024 Jul; 103(7):2337-2346. PubMed ID: 38849603
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.
    Neumann M; Beder T; Bastian L; Hänzelmann S; Bultmann M; Wolgast N; Hartmann A; Trautmann H; Ortiz-Tanchez J; Schlee C; Schroeder M; Fransecky L; Vosberg S; Fiedler W; Alakel N; Heberling L; Kondakci M; Starck M; Schwartz S; Raffel S; Müller-Tidow C; Schneller F; Reichle A; Burmeister T; Greif PA; Brüggemann M; Gökbuget N; Baldus CD
    Leukemia; 2024 Jun; 38(6):1213-1222. PubMed ID: 38744920
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anti-T-lymphocyte globulin exposure is associated with acute graft-
    Oostenbrink LVE; Von Asmuth EGJ; Jol-van der Zijde CM; Jansen-Hoogendijk AM; Vervat C; Bredius RGM; Van Tol MJD; Schilham MW; Sedlacek P; Ifversen M; Balduzzi A; Bader P; Peters C; Moes DJAR; Lankester AC
    Haematologica; 2024 Sep; 109(9):2854-2863. PubMed ID: 38721739
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]    [Full Text] [Related]  

  • 10. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
    Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; Hänel M; Dierlamm J; Pott C; Klapper W; Gözel D; Schmidt C; Unterhalt M; Ladetto M; Hoster E
    Lancet; 2024 May; 403(10441):2293-2306. PubMed ID: 38705160
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid leukemia.
    Dillon LW; Gui G; Ravindra N; Andrew G; Mukherjee D; Wong ZC; Huang Y; Gerhold J; Holman M; D'Angelo J; Miller J; Higgins J; Salk JJ; Auletta JJ; El Chaer F; Devine SM; Jimenez-Jimenez AM; De Lima MJG; Litzow MR; Kebriaei P; Saber W; Spellman SR; Zeger SL; Page KM; Hourigan CS
    JAMA Oncol; 2024 Aug; 10(8):1104-1110. PubMed ID: 38696205
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real world outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in adolescents and adults treated with intensive regimes.
    Panda T; Rainchwar S; Singh R; Singh A; Soni M; Kakkar D; Jegan KR; Pillai RH; Palatty RJ; Jha K; Ahmed R; Halder R; Tejwani N; Panda D; Bhurani D; Agrawal N
    Leuk Res; 2024 Jun; 141():107506. PubMed ID: 38663165
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
    Lo Presti V; Meringa A; Dunnebach E; van Velzen A; Moreira AV; Stam RW; Kotecha RS; Krippner-Heidenreich A; Heidenreich OT; Plantinga M; Cornel A; Sebestyen Z; Kuball J; van Til NP; Nierkens S
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580329
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Non-cancerous complications in HTLV-1 carriers.
    Ohmoto A; Fuji S
    Expert Rev Anti Infect Ther; 2024 May; 22(5):307-316. PubMed ID: 38536666
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. clinical Analysis of Pediatric Acute Megakaryocytic leukemia With CBFA2T3-GLIS2 Fusion Gene.
    Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid leukemia.
    Zhai Y; Shen H; Wei H
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Patient-Specific Measurable Residual Disease Markers Predict outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
    Tobiasson M; Pandzic T; Illman J; Nilsson L; Weström S; Ejerblad E; Olesen G; Björklund A; Olsnes Kittang A; Werlenius O; Lorentz F; Rasmussen B; Cammenga J; Weber D; Lindholm C; Wiggh J; Dimitriou M; Moen AE; Yip Lundström L; von Bahr L; Baltzer-Sollander K; Jädersten M; Kytölä S; Walldin G; Ljungman P; Groenbaek K; Mielke S; Jacobsen SEW; Ebeling F; Cavelier L; Smidstrup Friis L; Dybedal I; Hellström-Lindberg E
    J Clin Oncol; 2024 Apr; 42(12):1378-1390. PubMed ID: 38232336
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Validation of genes for H-ARS severity prediction in leukemia patients - interspecies comparison, challenges, and promises.
    Schwanke D; Valente M; Ostheim P; Schüle S; Bobyk L; Drouet M; Riccobono D; Magné N; Daguenet E; Stewart SJ; Muhtadi R; Port M; Abend M
    Int J Radiat Biol; 2024; 100(4):527-540. PubMed ID: 38227483
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
    Abdelbaky SB; Giacopelli B; Rabe KG; Yamaguchi K; Wu YZ; Yan H; Shanafelt TD; Parikh SA; Ding W; Hampel PJ; Brown S; Cerhan JR; Vachon CM; Kay NE; Hanson CA; Parker AS; Braggio E; Slager SL; Oakes CC
    Blood; 2024 Apr; 143(17):1752-1757. PubMed ID: 38194687
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research.
    Coupland SE; Du MQ; Ferry JA; de Jong D; Khoury JD; Leoncini L; Naresh KN; Ott G; Siebert R; Xerri L;
    J Pathol; 2024 Mar; 262(3):255-270. PubMed ID: 38180354
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 48.